As part of an application to the EIC Pathfinder Open 2026 call, EU-based industrial partners are sought to support scale-up, regulatory development, and first-in-human clinical translation of innovative small-molecule modulators and targeted nanomedicine platforms. Dual-action technologies selectively influence mitochondrial and bacterial ion pathways to reprogram tumor immunity and gut microbiota, boosting the efficacy of anti-Programmed death-1 (PD-1) immunotherapy.
Ref. BOTR20260811030 Fabricante textil turco ofrece tejidos innovadores y sostenibles a socios internacionales.
A Turkish textile manufacturer offers innovative and functional fabrics developed for fashion, apparel and interior applications. Combining accredited production facilities, strong R&D capabilities and a sustainability-oriented manufacturing approach, the...
Sep 15, 2026
















